A13212 | Pages: NA | Sep 2022 | 352 Views | ||
Author(s) : Onkar Sumant | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Musculoskeletal Disorders Drugs Market
Request Now !Musculoskeletal Disorders Drugs Market Outlook 2030
Musculoskeletal disorder are injuries or pain in the human musculoskeletal system which consists of joints, ligaments, muscles, nerves, tendons, and structures that support limbs. Musculoskeletal can be caused due to sudden exertion such as lifting a heavy object or making same movement repetitive causing strain. Musculoskeletal disorder can lead to improper functionality of joints and muscles. Self-reports, physical examination, and lab tests are used in diagnosis of this disorder. Non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen, & paracetamol, actonel, aldurazyme, salagen, and others are drugs which are used in the treatment of musculoskeletal disorder.
Market Scope and Structure Analysis
Report Metric | Details |
 Market Size available for years |  2020-2030 |
 Base year considered |  2020 |
 Forecast Period |  2021-2030 |
 Forecast Unit |  Value(USD) |
 Segments Covered | Disorder Type, Treatment Type, Route of Administration, Distribution Channel, and Region |
 Regions Covered | North America, Europe, Asia-Pacific, and LAMEA |
 Companies Covered | Bayer AG, Pfizer Inc., Sanofi, Zyla Life Sciences, Novartis AG, Johnson & Johnson Services, Inc., Merch & Co., Inc., Eli Lilly and Company, Abbott, ABIOGEN PHARMA S.p.A., Ampio Pharmaceuticals Inc. |
Â
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the musculoskeletal disorders drugs market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, Lincoln Pharma announced launch of diclofenac spray in Indian market. This spray results in quick pain relief and can be used in treatment of muscle spasm and other problems such as musculoskeletal disorders.
In 2019, Galt Pharmaceuticals announced U.S. Food and Drug Administration approval for launch of Orphengesic Forte. This product contain aspirin, caffeine, and orphenadrine for the treatment of pain caused due to musculoskeletal disorders.
Key Segments
Segment | Sub-segment |
 Disorder Type |
|
 Treatment Type |
|
 Route of Administration |
|
 Distribution Channel |
|
 Region |
|
Key Benefits of the Report
Questions Answered in the Musculoskeletal Disorders Drugs Market Report    Â
Key Market Segments & Key Market Players
Segments | Sub-segments |
---|---|
By  Disorder Type |
|
By Treatment Type |
|
By  Route of Administration |
|
By Distribution Channel |
|
By Region |
|
Key Market Players |
|
Loading Table Of Content...
Start reading.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers